Wemedoo Becomes an Associate Member of EUCROF

Partnership focuses on data standardization, real-time data management, and advanced technology solutions to streamline clinical trials across Europe.

Wemedoo is proud to announce its official acceptance as an Associate Member of the European CRO Federation (EUCROF). This membership reflects Wemedoo’s commitment to advancing clinical research by promoting structured, standardized clinical data and leveraging innovative technology to improve trial processes.

EUCROF, a leading organization representing contract research organizations across Europe, voted in favor of Wemedoo’s membership following a recent presentation to the Federation’s Management Board. The decision highlights the shared vision of both entities to drive efficiency and enhance data-driven decision-making in clinical studies.

“We see great potential in collaborating with EUCROF and its members to drive efficiency and innovation in clinical research. Our approach to real-time data management and interoperability aligns perfectly with EUCROF’s mission to improve clinical trial processes across Europe,” said Nina Cihoric, CEO at Wemedoo.

As an Associate Member, Wemedoo will actively engage with EUCROF’s extensive network, contribute to discussions on the future of clinical research, and support initiatives that enhance trial quality. This collaboration underscores Wemedoo’s dedication to pushing the boundaries of clinical data utilization and fostering a more efficient, patient-centric research environment.

For more information about Wemedoo’s technology-driven approach to clinical research, visit www.wemedoo.com.